A Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Not Applicable
Recruiting
- Conditions
- Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Xuanfei Baidu granuleDrug: Xuanfei Baidu granule Placebo
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 375
- Registration Number
- NCT06134063
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT06130579
- Locations
- 🇨🇳
Deparment of Hematology, Peking University People's Hospital, Beijing, Beijing, China
Endometrial Cancer Screening in High-risk Populations
Not Applicable
Not yet recruiting
- Conditions
- Cancer Screening
- Interventions
- Diagnostic Test: transvaginal ultrasound and microscale endometrial sampling biopsy
- First Posted Date
- 2023-11-09
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 22000
- Registration Number
- NCT06125886
ATG Plus Low-dose PT-Cy for GVHD Prevention
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 196
- Registration Number
- NCT06108739
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Phase 2
Recruiting
- Conditions
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- Interventions
- Drug: statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 38
- Registration Number
- NCT06102863
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
Phase 1
Not yet recruiting
- Conditions
- Stem Cell TransplantEBV InfectionCMV Infection
- Interventions
- Biological: Virus specific T cells
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT06075927
The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA
Phase 4
Recruiting
- Conditions
- Severe Aplastic Anemia
- Interventions
- Drug: Flu/Cy/ATG or Cy/ATG
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT06069180
- Locations
- 🇨🇳
Deparment of Hematology, Peking University People's Hospital, Beijing, Beijing, China
The Effect of Remote Diagnosis and Treatment on 24 Hour Ambulatory Blood Pressure Rhythm of OSA Patients
Not Applicable
Not yet recruiting
- Conditions
- Sleep Apnea, Obstructive
- Interventions
- Device: Automatic continuous positive airway pressure
- First Posted Date
- 2023-10-03
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06064630
NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy
- First Posted Date
- 2023-09-05
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06024031
- Locations
- 🇨🇳
Yuan Kong, Beijing, Beijing, China
Automitochondrial Transplantation Improves Live Birth in Elderly Patients With Low Prognosis After Repeated IVF Failure
Not Applicable
- Conditions
- Infertility, FemaleAssisted Reproductive TechniqueMitochondrialElderly
- Interventions
- Procedure: Autologous USC mitochondrial oocyte transplantation
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06020742
- Locations
- 🇨🇳
Peking University People's hospital, Peking, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath